Informations générales (source: ClinicalTrials.gov)
Evaluation of Low-energy Laser Therapy for Prevention and Reduction of Severity of Oral Mucositis in Children "Mucositis Laser 1"
Interventional
Phase 2/Phase 3
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
juin 2009
juillet 2010
29 juin 2024
Oral mucositis represents a major complication of cytotoxic chemotherapy among cancer in
children. Low-power laser therapy (LPLT) has been used to reduce the incidence of oral
mucositis in patients who are receiving high-dose chemotherapy. The aim of this study is
to compare two preventives energies delivered of LPLT to oral mucosa in decreasing the
severity of mucositis in children.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHU Clermont-Ferrand - 63000 - Clermont-Ferrand - France | Patrick LACARIN | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- 0 at 18 years
- patients receiving therapy with agents likely to cause severe mucositis (grade 3 or
4)
- Patients who had developed severe mucositis previously in any chemotherapy, and
receiving the same.
- Healthy oral mucosa
- informed consent
- 0 at 18 years
- patients receiving therapy with agents likely to cause severe mucositis (grade 3 or
4)
- Patients who had developed severe mucositis previously in any chemotherapy, and
receiving the same.
- Healthy oral mucosa
- informed consent
-
- Infection active and proved, viral, bacterial or fungal oral cavity
- Malignant pathology in the oral cavity
- Preliminary local irradiation of the oral cavity
- Simultaneous treatment by an agent of prevention or treatment of mucositis in
investigation
- Inclusion in a protocol with oral mucositis as one of the assessment criteria
- Absence of consent lit by parents or child